Literature DB >> 9344597

Effects of cyclin D1 overexpression on G1 progression-related events.

M Imoto1, Y Doki, W Jiang, E K Han, I B Weinstein.   

Abstract

In previous studies (W. Jiang, S. M. Kahn, P. Zhou, Y. (J. Zhang, A. M. Cacace, A. S. Infance, Y. Doi, R. M. Santella, and I. B. Weinstein 1993, Oncogene 8, 3447-3457) we reported that stable overexpression of cyclin D1 in R6 rat embryo fibroblasts shortens the G1 phase and impairs growth control. In the present study we examined the effects of cyclin D1 overexpression on other events involved in the G1 to S progression, utilizing the overexpressor cell line R6-ccnD1. We found that when compared to R6 control cells, serum-starved quiescent R6-ccnD1 cells had not only increased levels of the cyclin D1 protein but also increased levels of the cyclin E protein. The latter protein was complexed to phosphorylated cyclin-dependent kinase 2 (CDK2). However, in quiescent serum-starved R6-ccnD1 cells this cyclin E-CKD2 complex lacked in vitro kinase activity due to the presence of a heat-stable inhibitory activity, apparently reflecting the inhibitory effects of the CDK inhibitors (CDKIs) p21WAF1 and p27KIP1. Serum stimulation of the quiescent R6-ccnD1 cells was associated with a loss of this inhibitory activity and a decrease in the levels of the latter two proteins, as the cells progressed through the G1 phase. On the other hand, serum stimulation of the control R6 cells was associated with both induction of cyclin E and increased levels of phosphorylated CDK2 proteins and decreased levels of p21WAF1 and p27KIP1, as the cells progressed through the G1 phase. Thus, even though overexpression of cyclin D1 can induce the expression of cyclin E and phosphorylated CDK2, premature activation of cyclin E-CDK2 kinase activity in quiescent cells or during progression through G1 appears to be blocked by CDKIs. Nevertheless, the R6ccnD1 cells have a shorter G1 phase than the control cells presumably due to the high levels of both cyclin D1 and cyclin E. Taken together, these results indicate that overexpression of cyclin D, which is frequently seen in human tumors, can have complex effects on the expression of other genes that control cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344597     DOI: 10.1006/excr.1997.3713

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts.

Authors:  Darren J Perkins; Glen N Barber
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

2.  Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.

Authors:  K Komatsubara; S Tahara; K Umeoka; N Sanno; A Teramoto; R Y Osamura
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.

Authors:  D Mielcarek-Kuchta; J Olofsson; W Golusinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

4.  The D-type cyclin CYCD3;1 is limiting for the G1-to-S-phase transition in Arabidopsis.

Authors:  Margit Menges; Anne K Samland; Séverine Planchais; James A H Murray
Journal:  Plant Cell       Date:  2006-03-03       Impact factor: 11.277

5.  Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells.

Authors:  Bin Qin; Kun Cheng
Journal:  Breast Cancer Res       Date:  2010-09-23       Impact factor: 6.466

Review 6.  Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.

Authors:  Bei Zhang; Siqi Han; Bing Feng; Xiaoyuan Chu; Longbang Chen; Rui Wang
Journal:  Exp Mol Med       Date:  2017-02-10       Impact factor: 8.718

7.  HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.

Authors:  Fangfang Fu; Tian Wang; Zhangying Wu; Yourong Feng; Wenwen Wang; Su Zhou; Xiangyi Ma; Shixuan Wang
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

8.  Overexpression of phosphatidylinositol synthase enhances growth and G1 progression in NIH3T3 cells.

Authors:  Atsuko Deguchi; Kaoru Segawa; Kohei Hosaka; I Bernard Weinstein; Kazuo Umezawa
Journal:  Jpn J Cancer Res       Date:  2002-02

9.  Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines.

Authors:  Minjun Meng; Yanling Chen; Jianbo Jia; Lianghui Li; Sumei Yang
Journal:  Biol Res       Date:  2018-08-10       Impact factor: 5.612

10.  miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3'-UTR region of CyclinD1.

Authors:  Xiaoyu Fu; Deming Tan; Zhouhua Hou; Zhiliang Hu; Guozhen Liu
Journal:  Int J Mol Sci       Date:  2012-07-09       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.